在非ST段升高心肌梗塞后冠状动脉旁路移植的理想时机
Anthony V Norman1, Matthew P Weber1, Mohamad El Moheb1
1Division of Cardiothoracic Surgery, University of Virginia, Charlottesville, Virginia.
The Annals of thoracic surgery
|February 13, 2025
概括
对于非ST段升高心肌梗塞 (NSTEMI) 患者,在心脏导管注射后3至7天内进行冠状动脉旁路移植 (CABG) 与死亡风险最低相关. 这种时间可能会改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 非ST段升高心肌梗塞 (NSTEMI) 患者受益于重血管化.
- 在NSTEMI之后冠状动脉绕道移植 (CABG) 的最佳时间在当前的指导方针中仍然不清楚.
研究的目的:
- 确定在NSTEMI后患者进行CABG的理想时间.
主要方法:
- 一项多中心研究分析了10271名患有NSTEMI的患者,这些患者在心脏导管注射后30天内接受了隔离CABG.
- 根据CABG时间分组患者:≤2天,3至7天,8至30天.
- 多变量逻辑回归确定了死亡率的风险因素.
主要成果:
- 3至7天CABG组表现出最低的手术死亡率 (1.8%) 和主要发病率 (11%).
- 与其他群体相比,这个群体的预测死亡风险也较低.
- 风险调整后的分析显示,与较早 (≤2天) 或较晚 (8至30天) 的时间相比,在导管后3至7天进行CABG的死亡率显著降低.
结论:
- 在NSTEMI患者心脏导管治疗后3至7天内进行CABG与最低的死亡风险有关.
- 这3到7天的窗口可能代表CABG的最佳时间来改善NSTEMI患者的结果.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...


